About Acadia Pharmaceuticals Inc.
Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most.
We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome. And in early-stage clinical research, we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders.
Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity
Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. These communications may appear legitimate due to an official-looking Acadia email address or website, referencing of an actual recruiter and/or manager at Acadia (easily found on LinkedIn), and/or offer documents falsely signed by an Acadia executive. The impostor uses the incentive of a job interview and job offer to solicit sensitive personal information from the intended victim.
Please note that the Acadia Talent Acquisition and HR Team will ONLY interact with a candidate from "Acadia-pharm.com" domain sourced emails. We do not request sensitive personal information, such as a Social Security Number, or payments of any kind during the interview or job offer process. Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication’s legitimacy. If in doubt, please contact [email protected] to verify.
|
|
|
501-1,000 employees
View all Acadia Pharmaceuticals Inc. employees
|
|
Pharmaceuticals
|
|
(858) 558-2871
|
|
12830 El Camino Real, Suite 400, San Diego, California 92130-3331, US
|
|
1993
|
Acadia Pharmaceuticals Inc. Alternatives
Frequently Asked Questions about Acadia Pharmaceuticals Inc.
Steve Tan is the CEO of Acadia Pharmaceuticals Inc.. To contact Steve Tan email at [email protected].
The decision makers in Acadia Pharmaceuticals Inc. are Angela Chow, Doug Williamson, Doug Williamson, etc. Click to Find Acadia Pharmaceuticals Inc. decision makers emails.
Acadia Pharmaceuticals Inc. Staff Directory
Search Acadia Pharmaceuticals Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
